Financial
Parent UnitedHealth Group (UNH) group FY2025 revenue $447.57bn (+11.8%); operating margin 4.2%; net income $12.06bn.
Optum: revenue $270.6bn (+7%), earnings from operations $9.5bn.
HQ United Kingdom · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
Parent UnitedHealth Group (UNH) group FY2025 revenue $447.57bn (+11.8%); operating margin 4.2%; net income $12.06bn.
Optum: revenue $270.6bn (+7%), earnings from operations $9.5bn.
Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | US$447.6bn | +11.8% | US$19bn | US$12.1bn | UnitedHealth Group group |
Products not yet catalogued.
Parent UnitedHealth Group (UNH) group FY2025 revenue $447.57bn (+11.8%); operating margin 4.2%; net income $12.06bn.
Optum: revenue $270.6bn (+7%), earnings from operations $9.5bn.
Mar 2026: UnitedHealth Group completed the sale of Optum UK, whose core business is EMIS, to private equity firm TPG; terms were not officially disclosed, though Sky News had reported a value of about £1.2bn–£1.4bn.
No data breaches, cyber incidents or regulator action involving EMIS found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
No regulatory actions or clinical safety incidents attributed to EMIS products found in HSH's search of the last 24 months.
No significant new contracts, terminations or customer disputes involving EMIS found in HSH's search of the last 24 months.
No competitors linked yet.